Dopamine receptors influence the activity of the second messenger, cyclic AMP, which is involved in many biochemical processes within a neuron.[2] Dopamine receptor subtypes D1 and D5 increase levels of cyclic AMP, whereas D2, D3, and D4 subtypes decrease levels of cyclic AMP.[2] Thus, depending which receptor subtype the neurotransmitter binds with on the postsynaptic neuron, dopamine can increase or decrease activity in the postsynaptic neuron.[2]

Dopamine is critical to the underlying disease state of many conditions, including Parkinson’s disease, which is characterised by a dearth of dopamine, and schizophrenia, which appears to be caused by an overactivity of dopamine within certain brain regions.[3] Furthermore, many addictive substances work by altering the effect of dopamine within the brain.[1] For instance, cocaine appears to act by inhibiting the reuptake of dopamine, which leads to an increased concentration of dopamine in the synapse, thus prolonging the action of dopamine.[1]

References:
[1] Purves D, Augustine GJ, Fitzpatrick D, et al. (eds). Neuroscience. 6th edition. Sunderland, MA: Sinauer Associates, Inc. 2018.

[2] Kandel ER, Schwartz JH, Jessell TM (eds). Principles of Neural Science. 4th edition. McGraw-Hill, 2000.

[3] Stahl SM. Stahl’s Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. 4th edition. © Cambridge University Press, 2013.

[4] Napier TC, Kirby A, Persons AL. The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson’s disease. Prog Neuropsychopharmacol Biol Psychiatry 2020; 102: 109942.